S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Lacking counselors, US schools turn to the booming business of online therapy
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Chinese developer Evergrande risking liquidation if creditors veto its plan for handling huge debts
Kiss say farewell to live touring, become first US band to go virtual and become digital avatars
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war

Joint Stock Price, News & Analysis (NASDAQ:JYNT)

$9.26
+0.47 (+5.35%)
(As of 12/1/2023 ET)
Compare
Today's Range
$8.76
$9.28
50-Day Range
$7.37
$9.32
52-Week Range
$7.31
$20.00
Volume
137,036 shs
Average Volume
159,116 shs
Market Capitalization
$136.59 million
P/E Ratio
71.24
Dividend Yield
N/A
Price Target
$21.00

Joint MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
126.8% Upside
$21.00 Price Target
Short Interest
Bearish
4.75% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.91mentions of Joint in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$1.06 M Bought Last Quarter
Proj. Earnings Growth
100.00%
From $0.12 to $0.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

Medical Sector

84th out of 957 stocks

Patent Owners & Lessors Industry

1st out of 5 stocks


JYNT stock logo

About Joint Stock (NASDAQ:JYNT)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

JYNT Stock Price History

JYNT Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
The Joint Chiropractic Announces its "Back Friday" Deal
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Joint GAAP EPS of -$0.05, revenue of $29.5M
Recap: Joint Q3 Earnings
The Joint Chiropractic Expands into West Virginia
Joint (JYNT) Gets a Hold from Maxim Group
The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down
Joint Corp. to Cull About 10% of Owned or Managed Clinics
572K Reasons To Be Bullish On Joint Stock
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/03/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/14/2024

Industry, Sector and Symbol

Industry
Patent owners & lessors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JYNT
Employees
359
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.00
High Stock Price Target
$30.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+126.8%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$630,000.00
Pretax Margin
2.76%

Debt

Sales & Book Value

Annual Sales
$101.91 million
Cash Flow
$0.54 per share
Book Value
$2.39 per share

Miscellaneous

Free Float
14,164,000
Market Cap
$136.59 million
Optionable
Not Optionable
Beta
1.44
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Peter D. Holt (Age 64)
    CEO, President & Director
    Comp: $469.55k
  • Jake SingletonJake Singleton (Age 41)
    Chief Financial Officer
    Comp: $280.92k
  • Mr. Jorge Armenteros
    Senior Vice President of Operations
  • Mr. Charles Nelles
    Chief Technology Officer
  • Dr. Steven Knauf
    Vice President of Chiropractic & Compliance
  • Ms. Lori I. Abou Habib (Age 43)
    Chief Marketing Officer
  • Ms. Krischelle Tennessen
    Chief Human Resources Officer
  • Mr. Craig P. Colmar J.D. (Age 70)
    Secretary
    Comp: $37k














JYNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Joint stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price target for 2024?

4 equities research analysts have issued 12 month target prices for Joint's stock. Their JYNT share price targets range from $13.00 to $30.00. On average, they expect the company's stock price to reach $21.00 in the next year. This suggests a possible upside of 126.8% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2023?

Joint's stock was trading at $13.98 at the beginning of 2023. Since then, JYNT stock has decreased by 33.8% and is now trading at $9.26.
View the best growth stocks for 2023 here
.

Are investors shorting Joint?

Joint saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 700,200 shares, an increase of 18.9% from the October 31st total of 589,100 shares. Based on an average daily trading volume, of 146,400 shares, the days-to-cover ratio is currently 4.8 days.
View Joint's Short Interest
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024.
View our JYNT earnings forecast
.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) issued its earnings results on Thursday, November, 9th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.09. The business had revenue of $29.47 million for the quarter, compared to analysts' expectations of $29.55 million. Joint had a trailing twelve-month return on equity of 5.60% and a net margin of 1.69%.

What guidance has Joint issued on next quarter's earnings?

Joint updated its FY 2023 earnings guidance on Thursday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $115.00 million-$118.00 million, compared to the consensus revenue estimate of $116.23 million.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Who are Joint's major shareholders?

Joint's stock is owned by many different retail and institutional investors. Top institutional shareholders include Skylands Capital LLC (3.40%), First Foundation Advisors (1.01%), Northern Trust Corp (0.87%), Verus Capital Partners LLC (0.73%), O Brien Greene & Co. Inc (0.69%) and AQR Capital Management LLC (0.59%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:JYNT) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -